Company / Free Cash Flow
Bausch & Lomb Corp Free Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$66.0M
FY2025
5-year range
-$198.0M / $680.0M
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
#131 of 145
Health Care
What the data says
Among 145 Health Care companies, Bausch & Lomb Corp is in the bottom 10% for free cash flow. Free Cash Flow has fluctuated over the past 6 years, ranging from -$198M in FY2023 to $680M in FY2021.
Based on SEC 10-K filings.
-$66M in FY2025.
Improved from -$198M to -$66M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 145This company -$66.0M Sector average $770.9M
▼
-108.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 11.9% year-over-year.
- Ranks #131 out of 145 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$66.0M | -11.9% |
| FY2024 | -$59.0M | +70.2% |
| FY2023 | -$198.0M | -216.5% |
| FY2022 | $170.0M | -75.0% |
| FY2021 | $680.0M | +152.8% |
| FY2020 | $269.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026